# Duravelo-3 (NCT06840483)

> Study of Zelenectide Pevedotin in Participants With Advanced Breast Cancer

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT06840483
- Phase: PHASE2
- Status: ACTIVE_NOT_RECRUITING
- Sponsor: BicycleTx Limited
- Conditions: Breast Cancer
- Interventions: Zelenectide pevedotin (BT8009)
- Enrollment: 66
- Primary outcome: Objective response rate (ORR) per Response Evaluation Criteria in Solid Tumors per RECIST version 1.1 as assessed by the Investigator

## Indexed commentary on Duravelo-3 so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- X threads: 5

## Order

Focused, $750, price fixed at order: https://www.erudio.com/contact?report=duravelo-3-nct06840483